Kintor Pharmaceutical Ltd (HK:9939) has released an update.
Kintor Pharmaceutical’s Chairman, Dr. Youzhi Tong, has demonstrated his confidence in the company’s growth potential by purchasing 995,500 shares with his own funds, reinforcing the company’s commitment to dermatology and cosmetic products and its expansion into global markets. The company is set to diversify its cosmetic product line, planning to launch new items like acne cream and whitening essence, aiming to meet a wide range of consumer needs and boosting its global presence in key regions such as Japan, Europe, and Australia.
For further insights into HK:9939 stock, check out TipRanks’ Stock Analysis page.
